Monitoring by three laboratory methods of an oral GPIIb/IIIa anti-platelet agent in patients with vascular disease

被引：0
|
作者：
Ledford, MR
Canton, M
Preston, R
Gretler, DD
Enten, J
Alonso, A
Brito, MI
Delgado, L
Mitchell, M
机构：
[1] Univ Miami, Sch Med, Dept Pathol, Miami, FL 33152 USA
[2] Univ Miami, Sch Med, Dept Clin Pharmacol, Miami, FL 33152 USA
[3] Biocytex, Miami, FL USA
[4] COR Therapeut Inc, Marseille, France
[5] Beckman Coulter Corp, S San Francisco, CA USA
来源：
THROMBOSIS AND HAEMOSTASIS | 1999年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2601
引用
收藏
页码：821 / 821
页数：1
相关论文
共 50 条
  • [1] Glycoproteins Ib, IX, V and CD62P are not activated or inhibited by an oral GPIIb/IIIa anti-platelet agent given to patients with vascular disease
    Ledford, MR
    Canton, M
    Preston, R
    Gretler, DD
    Enten, J
    Alonso, A
    Brito, MI
    Delgado, L
    Mitchell, M
    THROMBOSIS AND HAEMOSTASIS, 1999, : 821 - 822
  • [2] The anti-platelet approach targeting the fibrinogen ligand of the GPIIb/IIIa receptor
    Tsikaris, V
    JOURNAL OF PEPTIDE SCIENCE, 2004, 10 (10) : 589 - 602
  • [3] Characterization of anti-platelet antagonist interaction with purified glycoprotein IIb-IIIa (GPIIb-IIIa)
    Haga, JH
    Slack, SM
    Jennings, LK
    THROMBOSIS AND HAEMOSTASIS, 1999, : 159 - 159
  • [4] Anti-platelet effects of GPIIb/IIIa and P-selectin antagonism, platelet activation, and binding to neutrophils
    Caron, A
    Théroêt, JF
    Mousa, SA
    Merhi, Y
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2002, 40 (02) : 296 - 306
  • [5] Applications of Anti-Platelet Monitoring in Catheterization Laboratory
    Debabrata Mukherjee
    David J. Moliterno
    Journal of Thrombosis and Thrombolysis, 2000, 9 : 293 - 301
  • [6] Applications of anti-platelet monitoring in catheterization laboratory
    Mukherjee, D
    Moliterno, DJ
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2000, 9 (03) : 293 - 301
  • [7] Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura - Role in production of anti-platelet autoantibody
    Kuwana, M
    Kaburaki, J
    Ikeda, Y
    JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07): : 1393 - 1402
  • [8] Characterization of the anti-platelet actions of FK419, a novel non-peptide antagonist of platelet GPIIb/IIIa
    Mihara, K
    Aoki, T
    Moriguchi, A
    Yamamoto, H
    Maeda, M
    Tojo, N
    Yamanaka, T
    Ohkubo, M
    Matsuoka, N
    Seki, J
    Mutoh, S
    DRUG DEVELOPMENT RESEARCH, 2004, 61 (04) : 233 - 241
  • [9] The anti-platelet and anti-thrombotic effects of FK633, a peptide-mimetic GPIIb/IIIa antagonist
    Aoki, T
    Cox, D
    Senzaki, K
    Seki, J
    Tanaka, A
    Takasugi, H
    Motoyama, Y
    THROMBOSIS RESEARCH, 1996, 81 (04) : 439 - 450
  • [10] Particular benefit of platelet GPIIb/IIIa blockade and full heparin in patients with peripheral vascular disease undergoing PTCA
    Miller, JM
    Godfrey, N
    Balog, C
    Lincoff, AM
    Topol, EJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 455A - 455A
12345